Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
27.7M
-
Shares change
-
+1.51M
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
+$58.6M
-
Put/Call ratio
-
0.04
-
Number of buys
-
39
-
Number of sells
-
-52
-
Price
-
$36.73
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q4 2021
129 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q4 2021.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.7M shares
of 132M outstanding shares and own 20.96% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.95M shares), PERCEPTIVE ADVISORS LLC (2.93M shares), FMR LLC (2.25M shares), BlackRock Inc. (1.8M shares), Ponoi Management, LLC (1.6M shares), Column Group LLC (1.4M shares), WELLINGTON MANAGEMENT GROUP LLP (1.37M shares), KPCB XV Associates, LLC (1.3M shares), STATE STREET CORP (1.24M shares), and VANGUARD GROUP INC (1.21M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.